Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;98(10):3608-16.
doi: 10.1002/jps.21664.

Iontophoretically enhanced ciclopirox delivery into and across human nail plate

Affiliations

Iontophoretically enhanced ciclopirox delivery into and across human nail plate

Jinsong Hao et al. J Pharm Sci. 2009 Oct.

Abstract

Transungual delivery of antifungal drugs is hindered by the low permeability of human nail plates, and as such, repeated dosing over a long period of time is necessary for effective treatment. The objectives of this study were to explore the possibilities of (a) enhancing the delivery of ciclopirox (CIC) across human nail plates and (b) sustaining CIC delivery from the larger resultant drug depot in the nail plates with constant voltage iontophoresis. In vitro passive and 9 V cathodal iontophoretic transport experiments of CIC across human nails were performed. Transungual CIC delivery with Penlac was the control. The amounts of CIC released from and deposited in the nails were determined in drug release and extraction experiments, respectively. Iontophoresis increased the flux of CIC permeated across the nail approximately 10 times compared to passive delivery from the same formulation or from Penlac. A significant amount of CIC was loaded into and released from the nails; the CIC concentrations were estimated to be above the minimum inhibitory concentrations of CIC for dermatophytic molds. The apparent transport lag time decreased in iontophoretic transport. The results demonstrate that iontophoresis was able to deliver an effective amount of CIC into and across the nails, and this suggests the feasibility of a constant voltage battery-powered transungual iontophoretic device.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative amounts of ciclopirox delivered across human nail plates at 9 h (Q9) and 24 h (Q24) in constant 9 V cathodal iontophoretic (dark bars), passive (gray bars), and Penlac® (open bars) transport experiments. Data represent the mean and standard deviation of 5-10 nail samples. The Q24 data for passive transport are the average of the 24-h data in the 24- and 94-h passive transport experiments.
Figure 2
Figure 2
Fluxes (J) of ciclopirox across human nail plates in constant 9 V cathodal iontophoretic and 94-h passive transport experiments. Data represent the mean and standard deviation of 5-10 nail samples.
Figure 3
Figure 3
Total amounts of ciclopirox released from the nail plates at 24 and 50 h after 9 V cathodal iontophoretic (dark bars), 24-h passive (gray bars), and Penlac® (open bars) delivery. Data represent the mean and standard deviation of 5-10 nail samples.
Figure 4
Figure 4
Amounts of ciclopirox extracted from the nail plates after constant 9 V cathodal iontophoretic, 24-h passive, and Penlac® transport and subsequent release experiments. Data represent the mean and standard deviation of 5-10 nail samples.

References

    1. Murdan S. 1st meeting on topical drug delivery to the nail. Expert Opin Drug Deliv. 2007;4:453–455. - PubMed
    1. Piraccini BM, Iorizzo M, Antonucci A, Tosti A. Treatment of nail disorders. Therapy. 2004;1:159–167.
    1. Drake LA, Patrick DL, Fleckman P, Andr J, Baran R, Haneke E, Sapede C, Tosti A. The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol. 1999;41:189–196. - PubMed
    1. Ajit C, Suvannasankha A, Zaeri N, Munoz SJ. Terbinafine-associated hepatotoxicity. Am J Med Sci. 2003;325:292–295. - PubMed
    1. Bohn M, Kraemer KT. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. J Am Acad Dermatol. 2000;43:S57–S69. - PubMed

Publication types